These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20346835)

  • 1. Bevacizumab vs. triamcinolone.
    Soheilian M; Rabbanikhah Z; Ramezani A; Kiavash V; Yaseri M; Peyman GA
    Ophthalmology; 2010 Apr; 117(4):855-855.e2. PubMed ID: 20346835
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
    Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.
    Penha FM; Maia M; Cardillo JA; Arevalo JF; Wu L; Rodriguez FJ; Berrocal MH; Farah ME;
    Acta Ophthalmol; 2012 Mar; 90(2):e160-1. PubMed ID: 21470386
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
    Guthoff R; Meigen T; Hennemann K; Schrader W
    Ophthalmologica; 2010; 224(5):319-24. PubMed ID: 20424494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Kumar V; Ghosh B; Raina UK; Goel N
    Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?
    Spitzer MS; Szurman P; Bartz-Schmidt KU
    J Cataract Refract Surg; 2008 Jun; 34(6):880; author reply 880-1. PubMed ID: 18498977
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
    Kim HD; Kang KD; Choi KS; Rhee MR; Lee SJ
    Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
    [No Abstract]   [Full Text] [Related]  

  • 14. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
    Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab and macular edema.
    Kumar A
    Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
    [No Abstract]   [Full Text] [Related]  

  • 16. [Triamcinolone acetonide bevacizumab performance in treatment and idiopathic macular spider veins].
    Cerbulescu B; Taina AL; Dinita M; Malaeanu R; Radocea R; Carstocea B
    Oftalmologia; 2010; 54(1):101-9. PubMed ID: 20540378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic macular oedema in 2011: what are the options for refractory cystic oedema?
    Wickremasinghe S
    Clin Exp Ophthalmol; 2011; 39(7):595-7. PubMed ID: 22452678
    [No Abstract]   [Full Text] [Related]  

  • 18. Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.
    Rodríguez-Blanco M; Marticorena J; Gómez-Ulla F
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):427-8. PubMed ID: 18642017
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and therapeutic challenges.
    Dinç UA; Yenerel NM; Görgün E; Yetik H; Kokame GT; Lim JI
    Retina; 2009 Feb; 29(2):275-9. PubMed ID: 18827730
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.